相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Longitudinal imaging of metabotropic glutamate 5 receptors during early and extended alcohol abstinence
Ansel T. Hillmer et al.
NEUROPSYCHOPHARMACOLOGY (2021)
mGlu5 function in the nucleus accumbens core during the incubation of methamphetamine craving
Conor H. Murray et al.
NEUROPHARMACOLOGY (2021)
Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients
Jenny Ceccarini et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects
Laura F. Cavallone et al.
PAIN (2020)
The pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humans
Katarina Varnas et al.
NEUROPHARMACOLOGY (2020)
Differential contribution of metabotropic glutamate receptor 5 common allosteric binding site residues to biased allosteric agonism
Kathy Sengmany et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
Krista J. Siefried et al.
CNS DRUGS (2020)
Transgenic Analyses of Homer2 Function Within Nucleus Accumbens Subregions in the Regulation of Methamphetamine Reward and Reinforcement in Mice
Chelsea N. Brown et al.
FRONTIERS IN PSYCHIATRY (2020)
12-and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment concepts
F. Kamp et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
The impact of glutamate infusion on postoperative NT-proBNP in patients undergoing coronary artery bypass surgery: a randomized study
Huiqi Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder A Review
Martin P. Paulus et al.
JAMA PSYCHIATRY (2020)
mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use
Sylvia M. L. Cox et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Structural insights into the activation of metabotropic glutamate receptors
Antoine Koehl et al.
NATURE (2019)
Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology
Kathy Sengmany et al.
NEUROPHARMACOLOGY (2019)
Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017
Mbabazi Kariisa et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis
Brian Chan et al.
ADDICTION (2019)
Gender differences in the behavioral and subjective effects of methamphetamine in healthy humans
Leah M. Mayo et al.
PSYCHOPHARMACOLOGY (2019)
Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups
Edna Soares et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Methamphetamine use and cognitive function: A systematic review of neuroimaging research
Sabrini Sabrini et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome
David Hessl et al.
PLOS ONE (2019)
Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results
Eriene A. Youssef et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis
Stephane Potvin et al.
ADDICTIVE BEHAVIORS (2018)
Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy
Samuel A. Barnes et al.
BIOLOGICAL PSYCHIATRY (2018)
Alcohol Addiction-Metabotropic Glutamate Receptor Subtype 5 and its Ligands: How They All Come Together?
Jaya Kumar et al.
CURRENT DRUG TARGETS (2018)
mGlu5-mediated signalling in developing astrocyte and the pathogenesis of autism spectrum disorders
Francesco Petrelli et al.
CURRENT OPINION IN NEUROBIOLOGY (2018)
mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia
Irene Sebastianutto et al.
CURRENT OPINION IN PHARMACOLOGY (2018)
Lower Limbic Metabotropic Glutamate Receptor 5 Availability in Alcohol Dependence
Gil Leurquin-Sterk et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis
Tania Lecomte et al.
PSYCHIATRY RESEARCH (2018)
Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder
Funda Akkus et al.
TRANSLATIONAL PSYCHIATRY (2018)
Hippocampal metabolites in asthma and their implications for cognitive function
Juliet L. Kroll et al.
NEUROIMAGE-CLINICAL (2018)
Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee et al.
DRUG AND ALCOHOL DEPENDENCE (2018)
Biased agonism and allosteric modulation of metabotropic glutamate receptor 5
Phuc N. H. Trinh et al.
CLINICAL SCIENCE (2018)
Results and evaluation of a first-in-human study of RG7342, an mGlu5 positive allosteric modulator, utilizing Bayesian adaptive methods
Stefan Sturm et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Homer1 Scaffold Proteins Govern Ca2+ Dynamics in Normal and Reactive Astrocytes
Lara Buscemi et al.
CEREBRAL CORTEX (2017)
Metabotropic glutamate receptor 5 as a potential target for smoking cessation
Cristiano Chiamulera et al.
PSYCHOPHARMACOLOGY (2017)
mGlu5 negative allosteric modulators: a patent review (2013-2016)
Kyle A. Emmitte
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease
M. -L. Rouzade-Dominguez et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster et al.
NEURON (2017)
Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly
Karen K. Szumlinski et al.
BIOLOGICAL PSYCHIATRY (2017)
Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study
Daniel Rutrick et al.
ADVANCES IN THERAPY (2017)
A critical role of striatal A2AR-mGlu5R interactions in modulating the psychomotor and drug-seeking effects of methamphetamine
Sherie R. Wright et al.
ADDICTION BIOLOGY (2016)
Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias
K. Sengmany et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects
Robert W. Gould et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Perirhinal Cortex mGlu5 Receptor Activation Reduces Relapse to Methamphetamine Seeking by Restoring Novelty Salience
Jamie Peters et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Association of Long-Term Nicotine Abstinence With Normal Metabotropic Glutamate Receptor-5 Binding
Funda Akkus et al.
BIOLOGICAL PSYCHIATRY (2016)
Measures of outcome for stimulant trials: ACTTION recommendations and research agenda
Brian D. Kiluk et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Prefrontal glutamate correlates of methamphetamine sensitization and preference
Kevin D. Lominac et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Metabotropic glutamate receptor 5-a promising target in drug development and neuroimaging
Rajapillai L. I. Pillai et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Negative Allosteric Modulators of Metabotropic Glutamate Receptors Subtype 5 in Addiction: a Therapeutic Window
Yoan Mihov et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training
Chien-Hsuan Huang et al.
JOURNAL OF NEUROCHEMISTRY (2016)
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease
Francois Tison et al.
MOVEMENT DISORDERS (2016)
ASTROCYTIC mGluR5 AND THE TRIPARTITE SYNAPSE
A. Panatier et al.
NEUROSCIENCE (2016)
Chronic methamphetamine self-administration disrupts cortical control of cognition
Aurelien Bernheim et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials
Elizabeth Berry-Kravis et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Methamphetamine potentiates HIV-1 gp120-mediated autophagy via Beclin-1 and Atg5/7 as a pro-survival response in astrocytes
Lu Cao et al.
CELL DEATH & DISEASE (2016)
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression A Randomized Clinical Trial
Jorge A. Quiroz et al.
JAMA PSYCHIATRY (2016)
Metabotropic glutamate receptor 5: a target for migraine therapy
Maggie W. Waung et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy
Hilary Highfield Nickols et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Homer 1a and mGluR5 phosphorylation in reward-sensitive metaplasticity: A hypothesis of neuronal selection and bidirectional synaptic plasticity
Tanya M. Marton et al.
BRAIN RESEARCH (2015)
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
Edythe D. London et al.
BRAIN RESEARCH (2015)
The Brain on Drugs: From Reward to Addiction
Nora D. Volkow et al.
CELL (2015)
A Randomized, Placebo-Controlled Trial of AFQ056 for the Treatment of Chorea in Huntington's Disease
Ralf Reilmann et al.
MOVEMENT DISORDERS (2015)
Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex
Michael D. Scofield et al.
NEUROPSYCHOPHARMACOLOGY (2015)
An animal model of differential genetic risk for methamphetamine intake
Tamara J. Phillips et al.
FRONTIERS IN NEUROSCIENCE (2015)
Imaging Glutamate Homeostasis in Cocaine Addiction with the Metabotropic Glutamate Receptor 5 Positron Emission Tomography Radiotracer [11C]ABP688 and Magnetic Resonance Spectroscopy
Diana Martinez et al.
BIOLOGICAL PSYCHIATRY (2014)
Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictors
Mary-Lynn Brecht et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans
L. M. Hulka et al.
MOLECULAR PSYCHIATRY (2014)
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Limbic system mGluR5 availability in cocaine dependent subjects: A high-resolution PET [11C]ABP688 study
M. S. Milella et al.
NEUROIMAGE (2014)
Interoception and drug addiction
Martin P. Paulus et al.
NEUROPHARMACOLOGY (2014)
Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors
Taiwo Akindipe et al.
METABOLIC BRAIN DISEASE (2014)
Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: A 1H MRS study at 3 Tesla
Candice E. Crocker et al.
SCHIZOPHRENIA RESEARCH (2014)
Location-Dependent Signaling of the Group 1 Metabotropic Glutamate Receptor mGlu5
Yuh-Jiin I. Jong et al.
MOLECULAR PHARMACOLOGY (2014)
mGluR5 is necessary for maintenance of methamphetamine-induced associative learning
A. A. Herrold et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Cellular distribution of AMPA receptor subunits and mGlu5 following acute and repeated administration of morphine or methamphetamine
Amy A. Herrold et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Imbalances in Prefrontal Cortex CC-Homer1 versus CC-Homer2 Expression Promote Cocaine Preference
Alexis W. Ary et al.
JOURNAL OF NEUROSCIENCE (2013)
An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans
Andy C. Dean et al.
NEUROPSYCHOPHARMACOLOGY (2013)
The Metabotropic Glutamate 5 Receptor Modulates Extinction and Reinstatement of Methamphetamine-Seeking in Mice
Rose Chesworth et al.
PLOS ONE (2013)
Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography
Funda Akkus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Attenuation of reinstatement of methamphetamine-, sucrose-, and food-seeking behavior in rats by fenobam, a metabotropic glutamate receptor 5 negative allosteric modulator
Lucas R. Watterson et al.
PSYCHOPHARMACOLOGY (2013)
Drop-out from addiction treatment: A systematic review of risk factors
Hanne H. Brorson et al.
CLINICAL PSYCHOLOGY REVIEW (2013)
Neurologic Manifestations of Chronic Methamphetamine Abuse
Daniel E. Rusyniak
PSYCHIATRIC CLINICS OF NORTH AMERICA (2013)
Evaluating the impact of community-based treatment options on methamphetamine use: findings from the Methamphetamine Treatment Evaluation Study (MATES)
Rebecca McKetin et al.
ADDICTION (2012)
The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers
W. O. Rohof et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Involvement of metabotropic glutamate receptor 5, AKT/PI3K Signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in astrocytes
Ankit Shah et al.
JOURNAL OF NEUROINFLAMMATION (2012)
GLUTAMICS-a randomized clinical trial on glutamate infusion in 861 patients undergoing surgery for acute coronary syndrome
Marten Vidlund et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats
Martin Hadamitzky et al.
PSYCHOPHARMACOLOGY (2012)
Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats
Carmela M. Reichel et al.
PSYCHOPHARMACOLOGY (2012)
Positive allosteric modulation of mGluR5 accelerates extinction learning but not relearning following methamphetamine self-administration
Peter R. Kufahl et al.
FRONTIERS IN PHARMACOLOGY (2012)
Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease
F. Zerbib et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
mGluR5 Positive Allosteric Modulation Enhances Extinction Learning Following Cocaine Self-Administration
Richard M. Cleva et al.
BEHAVIORAL NEUROSCIENCE (2011)
Discriminative stimulus effects of NMDA, AMPA, and mGluR5 glutamate receptor ligands in methamphetamine-trained rats
Thomas E. Wooters et al.
BEHAVIOURAL PHARMACOLOGY (2011)
Loss of Object Recognition Memory Produced by Extended Access to Methamphetamine Self-Administration is Reversed by Positive Allosteric Modulation of Metabotropic Glutamate Receptor 5
Carmela M. Reichel et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Psychiatric comorbidity in methamphetamine dependence
Ruth Salo et al.
PSYCHIATRY RESEARCH (2011)
Brain Region-Selective Cellular Redistribution of mGlu5 But Not GABAB Receptors Following Methamphetamine-Induced Associative Learning
Amy A. Herrold et al.
SYNAPSE (2011)
Neurobiology of the incubation of drug craving
Charles L. Pickens et al.
TRENDS IN NEUROSCIENCES (2011)
Amphetamine toxicities Classical and emerging mechanisms
Bryan K. Yamamoto et al.
ADDICTION REVIEWS 2 (2010)
Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction
M. Foster Olive
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Lower Brain Glutamate Is Associated With Cognitive Deficits in HIV Patients: A New Mechanism for HIV-Associated Neurocognitive Disorder
Thomas Ernst et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Positive Allosteric Modulation of mGluR5 Receptors Facilitates Extinction of a Cocaine Contextual Memory
Justin T. Gass et al.
BIOLOGICAL PSYCHIATRY (2009)
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
E. Berry-Kravis et al.
JOURNAL OF MEDICAL GENETICS (2009)
Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System
Masaki Tokunaga et al.
JOURNAL OF NEUROSCIENCE (2009)
mGluR5 Has a Critical Role in Inhibitory Learning
Jian Xu et al.
JOURNAL OF NEUROSCIENCE (2009)
Accruing Preclinical Evidence about Metabotropic Glutamate 5 Receptor Antagonists as Treatments for Drug Dependence Highlights the Irreplaceable Contributions of Animal Studies to the Discovery of New Medications for Human Disorders
Athina Markou
NEUROPSYCHOPHARMACOLOGY (2009)
mGluR5 Antagonism Attenuates Methamphetamine Reinforcement and Prevents Reinstatement of Methamphetamine-Seeking Behavior in Rats
Justin T. Gass et al.
NEUROPSYCHOPHARMACOLOGY (2009)
A Role for mGluR5 Receptors in Intravenous Methamphetamine Self-Administration
Megan P. H. Osborne et al.
DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES (2008)
Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use
Thomas Ernst et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Behavioral genetic contributions to the study of addiction-related amphetamine effects
Tamara J. Phillips et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
The incentive sensitization theory of addiction: some current issues
Terry E. Robinson et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2008)
Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain
Giuseppa Mudo et al.
BRAIN RESEARCH (2007)
The Homer family proteins
Yoko Shiraishi-Yamaguchi et al.
GENOME BIOLOGY (2007)
Escalation of methamphetamine self-administration in rats: a dose-effect function
O Kitamura et al.
PSYCHOPHARMACOLOGY (2006)
Glutamatergic neurotransmission and protein kinase C play a role in neuron-glia communication during the development of methamphetamine-induced psychological dependence
M Miyatake et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Mechanisms of neurotransmitter release by amphetamines: A review
D Sulzer et al.
PROGRESS IN NEUROBIOLOGY (2005)
Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the monkey subthalamic nucleus
M Kuwajima et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers
ED London et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats
K Golembiowska et al.
NEUROPHARMACOLOGY (2003)
Both metabotropic glutamate I and II receptors mediate augmentation of dopamine release from the striatum in methamphetamine-sensitized rats
T Shimazoe et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity
G Battaglia et al.
JOURNAL OF NEUROSCIENCE (2002)
分享论文
